MedTrace Logo

The Effect of North American Ginseng on Blood Pressure in Individuals With Hypertension

NCT00219960 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 52

Last updated 2005-09-22

No results posted yet for this study

Summary

To determine the effect of North American ginseng on blood pressure in individuals with hypertension.

Conditions

Interventions

DRUG

North American Ginseng (Panax Quinquefolius)

Sponsors & Collaborators

  • Ontario Ministry of Agriculture, Food and Rural Affairs

    collaborator OTHER_GOV

  • Ontario Ginseng Growers Association

    collaborator OTHER

  • Risk Factor Modification Centre

    lead OTHER

Principal Investigators

  • Vladimir Vuksan, PhD · Risk Factor Modification Centre, St. Michael's Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2001-04-30
Completion
2003-10-31

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00219960 on ClinicalTrials.gov